<DOC>
	<DOCNO>NCT00524329</DOCNO>
	<brief_summary>The purpose study compare treatment effect patient upper gastro-intestinal complaint elevate risk NSAID-associated GI-damage without elevate risk NSAID-associated damage ( determined treat physician ) .</brief_summary>
	<brief_title>Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug ( NSAID ) -Associated GI Damage</brief_title>
	<detailed_description />
	<mesh_term>Heartburn</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Patient upper gastrointestinal complaint ( define heartburn and/or regurgitation and/or nausea and/or bloat feeling ) treatment esomeprazole 20mg daily start ( consult 1 ) . Upper gastrointestinal complaint think relate NSAID use Patient use NSAID** follow condition : NSAID use start least one week 1st consultation expect continue unchanged coming period ( least consult 2 ) NSAID take least 3 day week ( ** ) OTC Prescription NSAID ( ** ) Conventional NSAID COX2 selective NSAID Use PPI and/or H2RA month precede study A history reflux disease , relate NSAID use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>upper GI-symptoms</keyword>
	<keyword>heartburn</keyword>
	<keyword>NSAID</keyword>
	<keyword>risk</keyword>
	<keyword>PPI</keyword>
	<keyword>Bloating</keyword>
	<keyword>Regurgitation</keyword>
</DOC>